Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin for bacteremia prevention in pediatric leukemia and HSCT
NCT01371656Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2011
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of levofloxacin in bacterial infection, sponsored by Children's Oncology Group. Started Sep 2011; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01371656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371656.